Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 172

1.

[Customised infectiology - Fecal microbiota transplantation : following the Clostridioides difficile pathway].

Galperine TK, Guery B.

Rev Med Suisse. 2019 Apr 10;15(646):776-779. French.

PMID:
30969490
2.

Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection: EXTEND study subgroup analyses.

Cornely OA, Vehreschild MJGT, Adomakoh N, Georgopali A, Karas A, Kazeem G, Guery B.

Eur J Clin Microbiol Infect Dis. 2019 Jun;38(6):1187-1194. doi: 10.1007/s10096-019-03525-y. Epub 2019 Mar 25.

3.

Isavuconazole brain penetration in cerebral aspergillosis.

Lamoth F, Mercier T, André P, Pagani JL, Pantet O, Maduri R, Guery B, Decosterd LA.

J Antimicrob Chemother. 2019 Jun 1;74(6):1751-1753. doi: 10.1093/jac/dkz050. No abstract available.

PMID:
30753519
4.

Clostridium difficile infection trials: what is the primary endpoint?

Guery B.

Lancet Infect Dis. 2019 Mar;19(3):219-220. doi: 10.1016/S1473-3099(18)30626-1. Epub 2019 Jan 29. No abstract available.

PMID:
30709664
5.

[Systemic biomarkers in respiratory tract infections].

Balmpouzis Z, Diamanti E, Kritikos A, Guery B, Nicod LP.

Rev Med Suisse. 2018 Nov 14;14(627):2074-2078. French.

PMID:
30427601
6.

Rational approach in the management of Pseudomonas aeruginosa infections.

Bassetti M, Vena A, Russo A, Croxatto A, Calandra T, Guery B.

Curr Opin Infect Dis. 2018 Dec;31(6):578-586. doi: 10.1097/QCO.0000000000000505.

PMID:
30299364
7.

How to manage Pseudomonas aeruginosa infections.

Bassetti M, Vena A, Croxatto A, Righi E, Guery B.

Drugs Context. 2018 May 29;7:212527. doi: 10.7573/dic.212527. eCollection 2018. Review.

8.

Native aortic valve endocarditis due to Pseudomonas stutzeri in a 91-year-old woman.

Héquette-Ruz R, Charpentier A, Delabriere I, Loiez C, Guery B, Puisieux F, Beuscart JB.

Med Mal Infect. 2018 Oct;48(7):492-494. doi: 10.1016/j.medmal.2018.04.399. Epub 2018 May 25. No abstract available.

PMID:
29807689
9.

Exploring ways to improve CDI outcomes.

Galpérine T, Guery B; French Group of Fecal Microbiota Transplantation (GFTF).

Med Mal Infect. 2018 Feb;48(1):10-17. doi: 10.1016/j.medmal.2017.10.009. Epub 2018 Jan 12. Review.

PMID:
29336930
10.

Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial.

Guery B, Menichetti F, Anttila VJ, Adomakoh N, Aguado JM, Bisnauthsing K, Georgopali A, Goldenberg SD, Karas A, Kazeem G, Longshaw C, Palacios-Fabrega JA, Cornely OA, Vehreschild MJGT; EXTEND Clinical Study Group.

Lancet Infect Dis. 2018 Mar;18(3):296-307. doi: 10.1016/S1473-3099(17)30751-X. Epub 2017 Dec 19.

PMID:
29273269
11.

Biphasic lung injury during Streptococcus pneumoniae infection in a murine model.

Prevotat A, Rouyer C, Gosset P, Kipnis E, Faure K, Guery B.

Med Mal Infect. 2018 Mar;48(2):103-113. doi: 10.1016/j.medmal.2017.11.001. Epub 2017 Nov 27.

PMID:
29191391
12.

Multidrug resistant (or antimicrobial-resistant) pathogens - alternatives to new antibiotics?

Brunel AS, Guery B.

Swiss Med Wkly. 2017 Nov 22;147:w14553. doi: 10.4414/smw.2017.14553. eCollection 2017. Review.

13.

The human NAIP-NLRC4-inflammasome senses the Pseudomonas aeruginosa T3SS inner-rod protein.

Grandjean T, Boucher A, Thepaut M, Monlezun L, Guery B, Faudry E, Kipnis E, Dessein R.

Int Immunol. 2017 Aug 1;29(8):377-384. doi: 10.1093/intimm/dxx047.

PMID:
28992059
14.

Is a chlorine dioxide wiping procedure suitable for the high-level disinfection of nasendoscopes?

Henoun Loukili N, Lemaitre N, Guery B, Gaillot O, Chevalier D, Mortuaire G.

J Infect Prev. 2017 Mar;18(2):78-83. doi: 10.1177/1757177416679879. Epub 2016 Dec 18.

15.

Treating Clostridium difficile infection in patients presenting with hematological malignancies: Are current guidelines applicable?

Robin C, Héquette-Ruz R, Guery B, Boyle E, Herbaux C, Galperine T.

Med Mal Infect. 2017 Dec;47(8):532-539. doi: 10.1016/j.medmal.2017.07.002. Epub 2017 Aug 16.

PMID:
28823390
16.

A Pseudomonas aeruginosa TIR effector mediates immune evasion by targeting UBAP1 and TLR adaptors.

Imbert PR, Louche A, Luizet JB, Grandjean T, Bigot S, Wood TE, Gagné S, Blanco A, Wunderley L, Terradot L, Woodman P, Garvis S, Filloux A, Guery B, Salcedo SP.

EMBO J. 2017 Jul 3;36(13):1869-1887. doi: 10.15252/embj.201695343. Epub 2017 May 8.

17.

Proposal for shorter antibiotic therapies.

Wintenberger C, Guery B, Bonnet E, Castan B, Cohen R, Diamantis S, Lesprit P, Maulin L, Péan Y, Peju E, Piroth L, Stahl JP, Strady C, Varon E, Vuotto F, Gauzit R; Recommendation Group of the SPILF.

Med Mal Infect. 2017 Mar;47(2):92-141. doi: 10.1016/j.medmal.2017.01.007. Epub 2017 Mar 6. Review.

PMID:
28279491
18.

Fecal Microbiota Transplantation: Do We Need Harmonization?

Galpérine T, Sokol H, Guery B.

Clin Infect Dis. 2017 May 1;64(9):1292. doi: 10.1093/cid/cix092. No abstract available.

PMID:
28158478
19.

Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University Hospital.

Pichenot M, Héquette-Ruz R, Le Guern R, Grandbastien B, Charlet C, Wallet F, Schiettecatte S, Loeuillet F, Guery B, Galperine T.

Infection. 2017 Aug;45(4):425-431. doi: 10.1007/s15010-017-0981-8. Epub 2017 Jan 24.

PMID:
28120176
20.

The aliphatic amidase AmiE is involved in regulation of Pseudomonas aeruginosa virulence.

Clamens T, Rosay T, Crépin A, Grandjean T, Kentache T, Hardouin J, Bortolotti P, Neidig A, Mooij M, Hillion M, Vieillard J, Cosette P, Overhage J, O'Gara F, Bouffartigues E, Dufour A, Chevalier S, Guery B, Cornelis P, Feuilloley MG, Lesouhaitier O.

Sci Rep. 2017 Jan 24;7:41178. doi: 10.1038/srep41178.

21.

Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in France.

Baro E, Galperine T, Denies F, Lannoy D, Lenne X, Odou P, Guery B, Dervaux B.

PLoS One. 2017 Jan 19;12(1):e0170258. doi: 10.1371/journal.pone.0170258. eCollection 2017.

22.

Haemophilus parainfluenzae endocarditis in young adults.

Faure E, Cannesson O, Schurtz G, Coisne A, Vincentelli A, Faure K, Guery B.

Med Mal Infect. 2017 Feb;47(1):58-60. doi: 10.1016/j.medmal.2016.05.007. Epub 2016 Oct 17. No abstract available.

PMID:
27765477
24.

Neither Neoplasia Nor Tuberculosis, but Francisella.

Mambie A, Wallet F, Scherman L, Armand S, Vervelle C, Faure K, Guery B, Titécat M, Loïez C.

Open Forum Infect Dis. 2016 Apr 27;3(2):ofw080. doi: 10.1093/ofid/ofw080. eCollection 2016 Apr.

25.

Inhibition of the Injectisome and Flagellar Type III Secretion Systems by INP1855 Impairs Pseudomonas aeruginosa Pathogenicity and Inflammasome Activation.

Anantharajah A, Faure E, Buyck JM, Sundin C, Lindmark T, Mecsas J, Yahr TL, Tulkens PM, Mingeot-Leclercq MP, Guery B, Van Bambeke F.

J Infect Dis. 2016 Oct 1;214(7):1105-16. doi: 10.1093/infdis/jiw295. Epub 2016 Jul 13.

PMID:
27412581
26.

Tryptophan catabolism in Pseudomonas aeruginosa and potential for inter-kingdom relationship.

Bortolotti P, Hennart B, Thieffry C, Jausions G, Faure E, Grandjean T, Thepaut M, Dessein R, Allorge D, Guery BP, Faure K, Kipnis E, Toussaint B, Le Gouellec A.

BMC Microbiol. 2016 Jul 8;16(1):137. doi: 10.1186/s12866-016-0756-x.

27.

Cefoxitin: An alternative to carbapenems in urinary tract infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae.

Mambie A, Vuotto F, Poitrenaud D, Weyrich P, Cannesson O, Dessein R, Faure K, Guery B, Galpérine T.

Med Mal Infect. 2016 Jun;46(4):215-9. doi: 10.1016/j.medmal.2016.04.008.

PMID:
27210283
28.

Preparedness of healthcare workers at French Ebola referral centres.

Tarantini C, Peretti-Watel P, Yazdanpana Y, Guery B, Chidiac C, Rapp C, Brouqui P.

New Microbes New Infect. 2015 Feb 17;6:40-1. doi: 10.1016/j.nmni.2014.12.005. eCollection 2015 Jul. No abstract available.

29.

[Antimicrobial stewardship policy: Improve the quality of medical practices and not subject the infectious diseases specialists].

Roger PM, Leroy J, Garrait V, Guery B.

Med Mal Infect. 2016 May;46(3):115-6. doi: 10.1016/j.medmal.2016.03.002. Epub 2016 Apr 7. French. No abstract available.

PMID:
27068605
30.

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways.

Faure E, Bortolotti P, Kipnis E, Faure K, Guery B.

J Vis Exp. 2016 Jan 13;(107):e53218. doi: 10.3791/53218.

31.

Antiviral therapy of primary cytomegalovirus infection with vascular thrombosis in immunocompetent adults.

Deconinck L, Flateau C, Pichenot M, Morell-Dubois S, Maillard H, Hatron PY, Guery B, Faure K.

Med Mal Infect. 2016 Mar;46(2):87-92. doi: 10.1016/j.medmal.2015.12.013. Epub 2016 Feb 2. Review.

PMID:
26850899
32.

Faecal microbiota transplantation in recurrent Clostridium difficile infection: Recommendations from the French Group of Faecal microbiota Transplantation.

Sokol H, Galperine T, Kapel N, Bourlioux P, Seksik P, Barbut F, Scanzi J, Chast F, Batista R, Joly F, Joly AC, Collignon A, Guery B, Beaugerie L; French Group of Faecal microbiota Transplantation (FGFT).

Dig Liver Dis. 2016 Mar;48(3):242-7. doi: 10.1016/j.dld.2015.08.017. Epub 2015 Sep 7.

PMID:
26433619
33.

[European Antibiotic Awareness Day: What is new in France?].

Pulcini C, Alfandari S, Ballereau F, Bonnet E, Bruneel F, Castan B, Chidiac C, Cohen R, Descamps D, Doco-Lecompte T, Gauzit R, Guéry B, Jarlier V, Lesprit P, Marcelin AG, Molina JM, Rabaud C, Riché A, Salmon-Céron D, Senneville E, Stahl JP, Tattevin P, Varon E, Roblot F; conseil d’administration de la SPILF.

Med Mal Infect. 2015 Sep;45(9):345-7. doi: 10.1016/j.medmal.2015.08.001. Epub 2015 Sep 26. French. No abstract available.

PMID:
26411783
34.

Protective role of murine norovirus against Pseudomonas aeruginosa acute pneumonia.

Thépaut M, Grandjean T, Hober D, Lobert PE, Bortolotti P, Faure K, Dessein R, Kipnis E, Guery B.

Vet Res. 2015 Sep 4;46:91. doi: 10.1186/s13567-015-0239-3.

35.

Correlation between cytotoxicity induced by Pseudomonas aeruginosa clinical isolates from acute infections and IL-1β secretion in a model of human THP-1 monocytes.

Anantharajah A, Buyck JM, Faure E, Glupczynski Y, Rodriguez-Villalobos H, De Vos D, Pirnay JP, Bilocq F, Guery B, Tulkens PM, Mingeot-Leclercq MP, Van Bambeke F.

Pathog Dis. 2015 Oct;73(7). pii: ftv049. doi: 10.1093/femspd/ftv049. Epub 2015 Jul 22.

36.

Extensive Inflammatory Gingival Tumor in a Young Nonsmoking Woman: Back to Basics.

Hajji F, Beraud G, Genay A, Raoul G, Faure K, Guery B, Ferri J.

J Craniofac Surg. 2015 Jul;26(5):e388-90. doi: 10.1097/SCS.0000000000001865.

PMID:
26163848
37.

Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric).

Bretonnière C, Leone M, Milési C, Allaouchiche B, Armand-Lefevre L, Baldesi O, Bouadma L, Decré D, Figueiredo S, Gauzit R, Guery B, Joram N, Jung B, Lasocki S, Lepape A, Lesage F, Pajot O, Philippart F, Souweine B, Tattevin P, Timsit JF, Vialet R, Zahar JR, Misset B, Bedos JP; Société de Réanimation de Langue Française (SRLF); Société Française d’Anesthésie et de Réanimation (SFAR).

Intensive Care Med. 2015 Jul;41(7):1181-96. doi: 10.1007/s00134-015-3853-7. Epub 2015 Jun 3.

PMID:
26077053
38.

Diguanylate cyclase DgcP is involved in plant and human Pseudomonas spp. infections.

Aragon IM, Pérez-Mendoza D, Moscoso JA, Faure E, Guery B, Gallegos MT, Filloux A, Ramos C.

Environ Microbiol. 2015 Nov;17(11):4332-51. doi: 10.1111/1462-2920.12856. Epub 2015 Apr 28.

39.

Specific detection of type II human chorionic gonadotropin beta subunit produced by trophoblastic and neoplastic cells.

Aldaz-Carroll L, Richon S, Dangles-Marie V, Cocquebert M, Fournier T, Troalen F, Stevens D, Guery B, Hersant AM, Guibourdenche J, Nordor A, Pecking A, Bellet D.

Clin Chim Acta. 2015 Apr 15;444:92-100. doi: 10.1016/j.cca.2015.02.009. Epub 2015 Feb 12.

40.

Antiadhesive properties of glycoclusters against Pseudomonas aeruginosa lung infection.

Boukerb AM, Rousset A, Galanos N, Méar JB, Thépaut M, Grandjean T, Gillon E, Cecioni S, Abderrahmen C, Faure K, Redelberger D, Kipnis E, Dessein R, Havet S, Darblade B, Matthews SE, de Bentzmann S, Guéry B, Cournoyer B, Imberty A, Vidal S.

J Med Chem. 2014 Dec 26;57(24):10275-89. doi: 10.1021/jm500038p. Epub 2014 Dec 8.

PMID:
25419855
41.

Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases.

Poissy J, Goffard A, Parmentier-Decrucq E, Favory R, Kauv M, Kipnis E, Mathieu D, van der Werf S, Guery B; MERS-CoV Biology Group.

J Clin Virol. 2014 Oct;61(2):275-8. doi: 10.1016/j.jcv.2014.07.002. Epub 2014 Jul 12. Erratum in: J Clin Virol. 2015 Feb,63:94. van der Werf, S [added].

PMID:
25073585
42.

Scavenging of reactive oxygen species by tryptophan metabolites helps Pseudomonas aeruginosa escape neutrophil killing.

Genestet C, Le Gouellec A, Chaker H, Polack B, Guery B, Toussaint B, Stasia MJ.

Free Radic Biol Med. 2014 Aug;73:400-10. doi: 10.1016/j.freeradbiomed.2014.06.003. Epub 2014 Jun 12. Review.

PMID:
24929180
43.

Hemodialysis without systemic anticoagulation: a prospective randomized trial to evaluate 3 strategies in patients at risk of bleeding.

Guéry B, Alberti C, Servais A, Harrami E, Bererhi L, Zins B, Touam M, Joly D.

PLoS One. 2014 May 13;9(5):e97187. doi: 10.1371/journal.pone.0097187. eCollection 2014.

44.

Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome.

Faure E, Mear JB, Faure K, Normand S, Couturier-Maillard A, Grandjean T, Balloy V, Ryffel B, Dessein R, Chignard M, Uyttenhove C, Guery B, Gosset P, Chamaillard M, Kipnis E.

Am J Respir Crit Care Med. 2014 Apr 1;189(7):799-811. doi: 10.1164/rccm.201307-1358OC.

PMID:
24555512
45.

Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?

Faure E, Poissy J, Goffard A, Fournier C, Kipnis E, Titecat M, Bortolotti P, Martinez L, Dubucquoi S, Dessein R, Gosset P, Mathieu D, Guery B.

PLoS One. 2014 Feb 14;9(2):e88716. doi: 10.1371/journal.pone.0088716. eCollection 2014.

46.

Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximab.

Heusele M, Clerson P, Guery B, Lambert M, Launay D, Lefevre G, Morell-Dubois S, Maillard H, Le Gouellec N, Hatron PY, Hachulla E.

Clin Rheumatol. 2014 Jun;33(6):799-805. doi: 10.1007/s10067-014-2509-2. Epub 2014 Feb 2.

47.

Candida albicans airway exposure primes the lung innate immune response against Pseudomonas aeruginosa infection through innate lymphoid cell recruitment and interleukin-22-associated mucosal response.

Mear JB, Gosset P, Kipnis E, Faure E, Dessein R, Jawhara S, Fradin C, Faure K, Poulain D, Sendid B, Guery B.

Infect Immun. 2014 Jan;82(1):306-15. doi: 10.1128/IAI.01085-13. Epub 2013 Oct 28.

48.

First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013.

Mailles A, Blanckaert K, Chaud P, van der Werf S, Lina B, Caro V, Campese C, Guéry B, Prouvost H, Lemaire X, Paty MC, Haeghebaert S, Antoine D, Ettahar N, Noel H, Behillil S, Hendricx S, Manuguerra JC, Enouf V, La Ruche G, Semaille C, Coignard B, Lévy-Bruhl D, Weber F, Saura C, Che D; investigation team.

Euro Surveill. 2013 Jun 13;18(24). pii: 20502.

49.

Coronavirus: need for a therapeutic approach.

Guery B, van der Werf S.

Lancet Infect Dis. 2013 Sep;13(9):726-7. doi: 10.1016/S1473-3099(13)70153-1. Epub 2013 Jun 17. No abstract available.

PMID:
23782860
50.

Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission.

Guery B, Poissy J, el Mansouf L, Séjourné C, Ettahar N, Lemaire X, Vuotto F, Goffard A, Behillil S, Enouf V, Caro V, Mailles A, Che D, Manuguerra JC, Mathieu D, Fontanet A, van der Werf S; MERS-CoV study group.

Lancet. 2013 Jun 29;381(9885):2265-72. doi: 10.1016/S0140-6736(13)60982-4. Epub 2013 May 30. Erratum in: Lancet. 2013 Jun 29;381(9885):2254.

PMID:
23727167

Supplemental Content

Support Center